Menu

Recent Interviews

Jared Scharf, CEO, Desert Gold Ventures Inc.

Jared Scharf
CEO | Desert Gold Ventures Inc.
4770 72nd St,, V4K 3N3 Delta (CAN)

jared.scharf@desertgold.ca

Desert Gold Ventures CEO Jared Scharf on West Africa and its potential


Stephan Dorfmeister, Finance Department, Deep Nature Project GmbH

Stephan Dorfmeister
Finance Department | Deep Nature Project GmbH
Untere Hauptstraße 168, 7122 Gols (AT)

office@deep-nature.at

+43 681 10139055

Like Aurora Cannabis and Canopy Growth, Deep Nature Project GmbH focuses on value chain


Alison Coutts, Executive Chairman, Memphasys Ltd.

Alison Coutts
Executive Chairman | Memphasys Ltd.
30 Richmond Road, 2140 Homebush West (AUS)

alison.coutts@memphasys.com

+61 2 8415 7300

Memphasys Executive Chairman Alison Coutts on in vitro fertilisation (IVF)


Jared Scharf, CEO, Desert Gold Ventures Inc.

Jared Scharf
CEO | Desert Gold Ventures Inc.
4770 72nd St,, V4K 3N3 Delta (CAN)

jared.scharf@desertgold.ca


Desert Gold Ventures CEO Jared Scharf on West Africa and its potential

03.06.2020

  • Gold

Desert Gold Ventures Inc. has recently announced that it has commenced phase 2 of its exploration program on its Senegal Mali Shear Zone (SMSZ) project in Western Mali. The 394 km2 SMSZ project is both named after, and, overlies a 38 km section of the Senegal Mali Shear Zone, which is related to large mines located both to the north and south, along strike, including B2 Gold’s Fekola Mine, Barrick’s Gounkoto and Loulo Mines and AngloGoldAshanti/Iamgold’s Sadiola and Yatela Mines.

Zum Interview


Stephan Dorfmeister, Finance Department, Deep Nature Project GmbH

Stephan Dorfmeister
Finance Department | Deep Nature Project GmbH
Untere Hauptstraße 168, 7122 Gols (AT)

office@deep-nature.at

+43 681 10139055


Like Aurora Cannabis and Canopy Growth, Deep Nature Project GmbH focuses on value chain

19.05.2020

  • Cannabis

Stephan Dorfmeister, has worked for many years as a consultant for financial strategy in international business and is co-founder of the Deep Nature Project GmbH and is responsible for the finance department.

Zum Interview



Alison Coutts, Executive Chairman, Memphasys Ltd.

Alison Coutts
Executive Chairman | Memphasys Ltd.
30 Richmond Road, 2140 Homebush West (AUS)

alison.coutts@memphasys.com

+61 2 8415 7300


Memphasys Executive Chairman Alison Coutts on in vitro fertilisation (IVF)

02.04.2020

  • Bio-separations

Memphasys Ltd (ASX: MEM) is an Australian publicly-listed bio-separations company developing and commercialising innovative separation techniques based on the Company's proprietary membrane technology. Memphasys’ first application of this technology platform is now being commercialised – the separation of the ‘best’ sperm from a semen sample for use in human in vitro fertilisation (IVF).

Zum Interview



Thomas Soltau, CEO, wallstreet:online capital AG

Thomas Soltau
CEO | wallstreet:online capital AG
Michaelkirchstraße 17/18, 10179 Berlin (D)

service@smartbroker.de

+49 30 27 57 76 464


Smartbroker - wallstreet:online capital AG CEO Thomas Soltau in an interview on the market launch

23.12.2019

  • Brokerage

The wallstreet:online group is expanding. A new online broker will expand the business model of the largest online financial community in the German-speaking region. In an interview, Thomas Soltau, member of the Board of Management, explains the strategy for the new "smartbroker". The plans are clearly defined; in the coming years, 200,000 customers are to be acquired for the online transaction business. With FondsDISCOUNT.de, wallstreet:online capital AG has already successfully established a leading independent fund broker on the Internet.

Zum Interview



Jonathan Summers, CEO, EXMceuticals Inc.

Jonathan Summers
CEO | EXMceuticals Inc.
1111 Alberni Street, Suite 1603, V6E 4V2 Vancouver (CAN)

jonathan@exmceuticals.com


EXMceuticals CEO Jonathan Summers on the medical cannabis market

16.12.2019

  • Cannabis

Jonathan Summers is the CEO of EXMceuticals and came on board in the second Quarter of this year. Mr. Summers worked for Goldman Sachs for 15 years, his last role as managing director for corporate finance and is now joining the young cannabis company with his capital markets experience. EXM is currently focused on planting large quantities of cannabis in Africa. EXM plans to sell the refined cannabis products as pure CBD and its components, mainly into Europe, once it has been processed through their R&D laboratory and refinery which is located in Lisbon, Portugal.

Zum Interview